DalsnaFinance › Analyst accuracy › UBS › MBX target
UBS reiterates Buy on MBX Biosciences stock ahead of Q4 obesity data
UBS reiterated a Buy rating and $90.00 price target on MBX Biosciences Inc (NASDAQ:MBX).
A fact about what UBS published, as reported by Investing.com, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.